| (19) |
 |
|
(11) |
EP 0 712 926 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
03.07.1996 Bulletin 1996/27 |
| (43) |
Date of publication A2: |
|
22.05.1996 Bulletin 1996/21 |
| (22) |
Date of filing: 13.10.1995 |
|
|
| (84) |
Designated Contracting States: |
|
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
| (30) |
Priority: |
18.10.1994 GB 9420956
28.04.1995 GB 9508704
10.05.1995 GB 9509425
|
| (71) |
Applicant: Akzo Nobel N.V. |
|
NL-6824 BM Arnhem (NL) |
|
| (72) |
Inventors: |
|
- McLoughlin, Marian F.
Belfast BT5, 6PN (IR)
- Nelson, Robert Thomas
Bangor, BT20 5RJ, Co.Down (IR)
|
| (74) |
Representative: Mestrom, Joannes Jozef Louis et al |
|
N.V. Organon,
Postbus 20
NL-5340 BH Oss
NL-5340 BH Oss (NL) |
|
| |
|
| (54) |
Fish pancreatic disease virus |
(57) There is described a novel virus which is the causative agent of fish pancreatic
disease, which is a serious disease affecting Atlantic salmon. A method of isolating
the virus through co-cultivation of infected tissues following by passage is described
and an isolated strain of the virus has been deposited.
The use of the virus, or proteins or polypeptide derived therefrom as a vaccine or
in diagnosis is described, together with genetically engineered constructs.